Kristi Baker

Title: Innovations of Kristi Baker

Introduction

Kristi Baker is an accomplished inventor based in Brookline, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic peptides. With a total of four patents to her name, Baker's work focuses on addressing critical health issues related to albumin levels in the body.

Latest Patents

One of her latest patents involves FC receptor (FcRn) binding peptides and their uses. This invention includes isolated polypeptides that specifically block the interaction between the neonatal Fc receptor (FcRn) and albumin. By blocking this interaction, the invention aims to treat diseases and conditions caused by increased amounts of albumin or modified albumin that possess pathogenic properties. The methods provided also include using these isolated polypeptides to treat various diseases linked to elevated albumin levels. Additionally, the invention encompasses isolated polypeptides capable of binding to a non-IgG and non-albumin competitive site on an FcRn alpha 3 domain. These polypeptides can be useful for tracking FcRn without inhibiting IgG or albumin binding or function.

Career Highlights

Throughout her career, Kristi Baker has worked with prestigious organizations, including Brigham and Women's Hospital, Inc. and Biogen MA Inc. Her innovative research has contributed to advancements in therapeutic strategies for managing diseases related to albumin.

Collaborations

Baker has collaborated with notable professionals in her field, including Richard S. Blumberg and Timo Rath. These collaborations have further enhanced her research and development efforts.

Conclusion

Kristi Baker's contributions to the field of biomedical research through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic approaches to managing health conditions related to albumin.